Tech Company Financing Transactions

Tiburio Therapeutics Funding Round

Tiburio Therapeutics, operating out of Cambridge, secured $31 million from Alexandria Venture Investments, Longitude Capital Management and Lundbeckfond Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

700 Technology Square 2nd Floor
Cambridge, MA 02139
USA

Phone

617.231.6050

Website

www.tiburio.com

Email Address

[email protected]

Overview

Tiburio is a clinical stage biopharmaceutical company dedicated to advancing novel treatments for rare neuroendocrine tumors and rare endocrine diseases where there is significant patient need.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Abraham Ceesay

        

Chief Medical Officer

Shi Foo

        

Browse more venture capital transactions:

Prev: 1/4/2019: Preemadonna venture capital transaction
Next: 1/4/2019: Cabaletta Bio venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary